Last reviewed · How we verify

A First-In-Human Clinical Trial to Evaluate the Safety, Effectiveness and Surgical Characteristics of CADENCE in Patients With Refractory Glaucoma

NCT05131087 NA COMPLETED

To evaluate safety, effectiveness, and the surgical performance of CADENCE in patients with refractory glaucoma.

Details

Lead sponsorNew World Medical, Inc.
PhaseNA
StatusCOMPLETED
Enrolment30
Start dateThu Oct 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionWed Jul 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Mexico